| Daniel David Nahum, MD | |
|
3470 Blazer Pkwy, Lexington, KY 40509-1200 | |
| (859) 323-6021 | |
| Not Available |
| Full Name | Daniel David Nahum |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 3470 Blazer Pkwy, Lexington, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013090141 | NPI | - | NPPES |
| 64174410 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 17441 (Kentucky) | Primary |
| 2084P0802X | Psychiatry & Neurology - Addiction Psychiatry | 17441 (Kentucky) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Daniel David Nahum, MD 2333 Alumni Park Plz, Suite 200, Lexington, KY 40517-4012 Ph: (859) 257-7910 | Daniel David Nahum, MD 3470 Blazer Pkwy, Lexington, KY 40509-1200 Ph: (859) 323-6021 |
News Archive
Broadening the reach of two of its flagship aesthetic laser products into the Asia Pacific region, Cynosure, Inc. today announced that it has received approval to market the Smartlipo MPX(TM) LaserBodySculpting(SM) Workstation in Korea and the Affirm(TM) Anti-Aging Workstation in the People's Republic of China.
In older age groups, repeated suicide attempts constitute an increased risk for completed suicide in depressed women, while severe attempts constitute an increased risk for depressed men. Researchers writing in the open access journal BMC Psychiatry studied suicide attempts in 100 patients who committed suicide and in an age- and sex-matched control group, investigating the effects of age on suicidal behaviour, as a risk factor for accomplished suicide.
KINAXO Biotechnologies GmbH announced today that it has entered into a collaboration with AstraZeneca. Under the terms of the agreement, KINAXO will apply its technology platform to support one of AstraZeneca's oncology programs. KINAXO will employ high-end mass spectrometry-based technologies to quantitatively analyze posttranslational protein modifications on a proteome-wide scale.
New research indicates that a disruption of brain signals for reward and punishment contributes to increased pain sensitivity, known as hyperalgesia, in fibromyalgia patients. Results published in Arthritis & Rheumatism, a journal of the American College of Rheumatology, suggest that this altered brain processing might contribute to widespread pain and lack of response to opioid therapy in patients with fibromyalgia.
Researchers have shown for the first time that patterns of ultrasound signals can be used to identify whether or not cancer has started to spread in melanoma patients, and to what extent. The discovery enables doctors to decide on how much surgery, if any, is required and to predict the patient's probable survival.
› Verified 7 days ago
Dr. David Neil Toupin, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2195 Harrodsburg Rd Fl 2, Lexington, KY 40504 Phone: 859-562-1868 Fax: 859-257-0421 | |
Dr. Daniella Gavito, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 245 Fountain Ct # 225, Lexington, KY 40509 Phone: 859-323-6021 | |
Dr. Scott Littleton, M.D, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: University Health Service, 830 South Limestone Street, Lexington, KY 40536 Phone: 859-323-5511 Fax: 859-257-9816 | |
Amanda May Leuthold, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 245 Fountain Ct, Lexington, KY 40509 Phone: 859-323-6021 Fax: 859-323-1670 | |
Charles I Shelton Jr., D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1350 Bull Lea Rd, Lexington, KY 40511 Phone: 859-246-8000 Fax: 859-246-8043 | |
Dr. Shri K Vaish, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3217 Linville Ln, Lexington, KY 40513 Phone: 937-270-4295 |